Lower limb multilevel treatment with drug-Eluting balloons: 6-Month results from the DEBELLUM randomized trial

Journal of Endovascular Therapy

Volumn 19, Issue 5, 2012, Pages 571-580

  Fanelli, Fabrizio ^a   Cannavale, Alessandro ^a   Boatta, Emanuele ^a   Corona, Mario ^a   Lucatelli, Pierleone ^a   Wlderk, Andrea ^a   Cirelli, Carlo ^a   Salvatori, Filippo Maria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Amputation; Angioplasty; Critical limb ischemia; Drug eluting balloon; Infrapoplitealarteries; Late lumen loss; Occlusion; Paclitaxel; Peripheral artery disease; Poplitealartery; Restenosis; Stenosis; Stent; Superficial femoralartery; Target lesion revascularization; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL;

AGED; ANGIOPLASTY; ANKLE BRACHIAL INDEX; ARTERY LESION; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FEMORAL ARTERY; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; LEG AMPUTATION; LEG THROMBOSIS; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION;

AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CARDIOVASCULAR AGENTS; CONSTRICTION, PATHOLOGIC; DRUG CARRIERS; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; HUMANS; LIMB SALVAGE; LOWER EXTREMITY; MALE; MIDDLE AGED; PACLITAXEL; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RECURRENCE; ROME; SEVERITY OF ILLNESS INDEX; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES;

EID: 84868381885     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/JEVT-12-3926MR.1     Document Type: Article

References (22)

1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75.
2. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699.
3. Dake MD, Scheinert D, Tepe G, et al.; Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: Twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther. 2011; 18:613-623.
4. Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial. Circulation. 2008;118:1358-1365.
5. Scheller B. Opportunities and limitations of drug-coated balloons in interventional therapies. Herz. 2011;36:232-239.
6. Chan YC, Cheng SW. Drug-eluting stents and balloons in peripheral arterial disease: Evidence so far. Int J Clin Pract. 2011;65:664-668.
7. Dake MD, Ansel GM, Jaff MR, et al. Paclitaxeleluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: Twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495-504.
8. Schmidt A, Piorkowski M, Werner M, et al. First experience with drug-eluting balloons in infrapopliteal arteries: Restenosis rate and clinical outcome. J Am Coll Cardiol. 2011;58:1105-1109.
9. Feiring AJ, Krahn M, Nelson L, et al. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: The PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol. 2010; 55:1580-1589.
10. Balzer JO, Zeller T, Rastan A, et al. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents. J Cardiovasc Surg (Torino). 2010;51: 183-191.
11. Rastan A, Schwarzwälder U, Noory E, et al. Primary use of sirolimus-eluting stents in the infrapopliteal arteries. J Endovasc Ther. 2010; 17:480-487.
12. Diehm NA, Hoppe H, Do DD. Drug eluting balloons. Tech Vasc Interv Radiol. 2010;13:59-63.
13. Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg. 2012;55:390-398.
14. Mauri L, Orav EJ, Candia SC, et al. Robustness of late lumen loss in discriminating drugeluting stents across variable observational and randomized trials. Circulation. 2005;112: 2833-2939.
15. Baumann F, Willenberg T, Do DD, et al. Endovascular revascularization of below-theknee arteries: Prospective short-term angiographic and clinical follow-up. J Vasc Interv Radiol. 2011;22:1665-1673.
16. Sharma S, Kukreja N, Christopoulos C, et al. Drug-eluting balloon: New tool in the box. Expert Rev Med Devices. 2010;7:381-388.
17. Cremers B, Speck U, Kaufels N, et al. Drugeluting balloon: Very short-term exposure and overlapping. Thromb Haemost. 2009;101:201-206.
18. Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810-814.
19. Micari A, Cioppa A, Vadalà G, et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease. 12-month results from a multicenter Italian Registry. JACC Cardiovasc Interv. 2012;5:331-338.
20. Zeller T, Schmitmeier S, Tepe G, et al. Drugcoated balloons in the lower limb. J Cardiovasc Surg (Torino). 2011;52:235-243.
21. Werk M, Albrecht T, Meyer DR, et al. The PACIFIER trial: A randomized multicenter trial evaluating prevention of restenosis with paclitaxel-coated PTA balloon catheters in stenosis or occlusion of femoropopliteal arteries. Presented at LINC 2012 held in Leipzig, Germany, January 25-28, 2012. Available at: Http://www. leipzig-interventional-course.com/index.php? option=com-docman&task=doc-download&gid=1053. Last accessed June 6, 2012.
22. Schmidt A, Ulrich M, Winkler B, et al. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv. 2010;76:1047-1054.